Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Current Leases (2023 - 2025)

Analysis

Inventiva (IVA) Current Leases (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 6.64 Mn
Dec 31, 2024 6.27 Mn
Jun 30, 2024 5.72 Mn
Jun 30, 2023 6.37 Mn